-
1
-
-
84895529499
-
Sitagliptin added to previously taken antidiabetic agents on insulin resistance and lipid profile: A 2-year study evaluation
-
G. Derosa, P.D. Ragonesi, E. Fogari, A.F. Cicero, L. Bianchi, A. Bonaventura, and et al. Sitagliptin added to previously taken antidiabetic agents on insulin resistance and lipid profile: a 2-year study evaluation Fundam. Clin. Pharmacol. 28 2014 221 229
-
(2014)
Fundam. Clin. Pharmacol.
, vol.28
, pp. 221-229
-
-
Derosa, G.1
Ragonesi, P.D.2
Fogari, E.3
Cicero, A.F.4
Bianchi, L.5
Bonaventura, A.6
-
2
-
-
84881507403
-
Preventive effect of dipeptidyl peptidase-4 inhibitor on atherosclerosis is mainly attributable to incretin's actions in nondiabetic and diabetic apolipoprotein E-null mice
-
M. Terasaki, M. Nagashima, K. Nohtomi, K. Kohashi, M. Tomoyasu, K. Sinmura, and et al. Preventive effect of dipeptidyl peptidase-4 inhibitor on atherosclerosis is mainly attributable to incretin's actions in nondiabetic and diabetic apolipoprotein E-null mice PLoS One 8 2013 e70933
-
(2013)
PLoS One
, vol.8
, pp. e70933
-
-
Terasaki, M.1
Nagashima, M.2
Nohtomi, K.3
Kohashi, K.4
Tomoyasu, M.5
Sinmura, K.6
-
3
-
-
81855222104
-
Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis
-
Z. Shah, T. Kampfrath, J.A. Deiuliis, J. Zhong, C. Pineda, Z. Ying, and et al. Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis Circulation 124 2011 2338 2349
-
(2011)
Circulation
, vol.124
, pp. 2338-2349
-
-
Shah, Z.1
Kampfrath, T.2
Deiuliis, J.A.3
Zhong, J.4
Pineda, C.5
Ying, Z.6
-
4
-
-
84862908699
-
A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice
-
J. Matsubara, S. Sugiyama, K. Sugamura, T. Nakamura, Y. Fujiwara, E. Akiyama, and et al. A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice J. Am. Coll. Cardiol. 59 2012 265 276
-
(2012)
J. Am. Coll. Cardiol.
, vol.59
, pp. 265-276
-
-
Matsubara, J.1
Sugiyama, S.2
Sugamura, K.3
Nakamura, T.4
Fujiwara, Y.5
Akiyama, E.6
-
5
-
-
80051785333
-
DPP-4 (CD26) inhibitor alogliptin inhibits atherosclerosis in diabetic apolipoprotein E-deficient mice
-
N.N. Ta, C.A. Schuyler, Y. Li, M.F. Lopes-Virella, and Y. Huang DPP-4 (CD26) inhibitor alogliptin inhibits atherosclerosis in diabetic apolipoprotein E-deficient mice J. Cardiovasc. Pharmacol. 58 2011 157 166
-
(2011)
J. Cardiovasc. Pharmacol.
, vol.58
, pp. 157-166
-
-
Ta, N.N.1
Schuyler, C.A.2
Li, Y.3
Lopes-Virella, M.F.4
Huang, Y.5
-
6
-
-
84874597960
-
Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice
-
N. Ervinna, T. Mita, E. Yasunari, K. Azuma, R. Tanaka, S. Fujimura, and et al. Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice Endocrinology 154 2013 1260 1270
-
(2013)
Endocrinology
, vol.154
, pp. 1260-1270
-
-
Ervinna, N.1
Mita, T.2
Yasunari, E.3
Azuma, K.4
Tanaka, R.5
Fujimura, S.6
-
7
-
-
84871686739
-
GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice
-
N. Panjwani, E.E. Mulvihill, C. Longuet, B. Yusta, J.E. Campbell, T.J. Brown, and et al. GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice Endocrinology 154 2013 127 139
-
(2013)
Endocrinology
, vol.154
, pp. 127-139
-
-
Panjwani, N.1
Mulvihill, E.E.2
Longuet, C.3
Yusta, B.4
Campbell, J.E.5
Brown, T.J.6
-
8
-
-
84862010640
-
Upregulation of SDF-1 is associated with atherosclerosis lesions induced by LDL concentration polarization
-
D. Wei, G. Wang, C. Tang, J. Qiu, J. Zhao, H. Gregersen, and et al. Upregulation of SDF-1 is associated with atherosclerosis lesions induced by LDL concentration polarization Ann. Biomed. Eng. 40 2012 1018 1027
-
(2012)
Ann. Biomed. Eng.
, vol.40
, pp. 1018-1027
-
-
Wei, D.1
Wang, G.2
Tang, C.3
Qiu, J.4
Zhao, J.5
Gregersen, H.6
-
9
-
-
0033964318
-
The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques
-
S. Abi-Younes, A. Sauty, F. Mach, G.K. Sukhova, P. Libby, and A.D. Luster The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques Circ. Res. 86 2000 131 138
-
(2000)
Circ. Res.
, vol.86
, pp. 131-138
-
-
Abi-Younes, S.1
Sauty, A.2
Mach, F.3
Sukhova, G.K.4
Libby, P.5
Luster, A.D.6
-
10
-
-
84897943212
-
Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysis
-
E. Shantsila, L.D. Tapp, B.J. Wrigley, B. Pamukcu, S. Apostolakis, S. Montoro-Garcia, and et al. Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysis Atherosclerosis 234 2014 4 10
-
(2014)
Atherosclerosis
, vol.234
, pp. 4-10
-
-
Shantsila, E.1
Tapp, L.D.2
Wrigley, B.J.3
Pamukcu, B.4
Apostolakis, S.5
Montoro-Garcia, S.6
-
11
-
-
84898017437
-
Atorvastatin inhibits CXCR7 induction to reduce macrophage migration
-
W. Ma, Y. Liu, C. Wang, L. Zhang, L. Crocker, and J. Shen Atorvastatin inhibits CXCR7 induction to reduce macrophage migration Biochem. Pharmacol. 89 2014 99 108
-
(2014)
Biochem. Pharmacol.
, vol.89
, pp. 99-108
-
-
Ma, W.1
Liu, Y.2
Wang, C.3
Zhang, L.4
Crocker, L.5
Shen, J.6
-
13
-
-
84901467299
-
Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct
-
U.M. Gundra, N.M. Girgis, D. Ruckerl, S. Jenkins, L.N. Ward, Z.D. Kurtz, and et al. Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct Blood 123 2014 e110 e122
-
(2014)
Blood
, vol.123
, pp. e110-e122
-
-
Gundra, U.M.1
Girgis, N.M.2
Ruckerl, D.3
Jenkins, S.4
Ward, L.N.5
Kurtz, Z.D.6
-
14
-
-
70349581878
-
Macrophage diversity and polarization in atherosclerosis: A question of balance
-
A. Mantovani, C. Garlanda, and M. Locati Macrophage diversity and polarization in atherosclerosis: a question of balance Arterioscler. Thromb. Vasc. Biol. 29 2009 1419 1423
-
(2009)
Arterioscler. Thromb. Vasc. Biol.
, vol.29
, pp. 1419-1423
-
-
Mantovani, A.1
Garlanda, C.2
Locati, M.3
-
17
-
-
84886284739
-
Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction
-
H.D. Theiss, L. Gross, M. Vallaster, R. David, S. Brunner, C. Brenner, and et al. Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction Int. J. Cardiol. 168 2013 3359 3369
-
(2013)
Int. J. Cardiol.
, vol.168
, pp. 3359-3369
-
-
Theiss, H.D.1
Gross, L.2
Vallaster, M.3
David, R.4
Brunner, S.5
Brenner, C.6
-
18
-
-
80052661942
-
Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis
-
H.D. Theiss, M. Vallaster, C. Rischpler, L. Krieg, M.M. Zaruba, S. Brunner, and et al. Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis Stem Cell Res. 7 2011 244 255
-
(2011)
Stem Cell Res.
, vol.7
, pp. 244-255
-
-
Theiss, H.D.1
Vallaster, M.2
Rischpler, C.3
Krieg, L.4
Zaruba, M.M.5
Brunner, S.6
-
19
-
-
58149361845
-
Rapid quantification of aortic lesions in apoE(-/-) mice
-
J.H. Beattie, S.J. Duthie, I.S. Kwun, T.Y. Ha, and M.J. Gordon Rapid quantification of aortic lesions in apoE(-/-) mice J. Vasc. Res. 46 2009 347 352
-
(2009)
J. Vasc. Res.
, vol.46
, pp. 347-352
-
-
Beattie, J.H.1
Duthie, S.J.2
Kwun, I.S.3
Ha, T.Y.4
Gordon, M.J.5
-
20
-
-
0025215247
-
Power and sample size calculations. A review and computer program
-
W.D. Dupont, and W.D. Plummer Jr. Power and sample size calculations. A review and computer program Control. Clin. Trials 11 1990 116 128
-
(1990)
Control. Clin. Trials
, vol.11
, pp. 116-128
-
-
Dupont, W.D.1
Plummer, W.D.2
-
21
-
-
4043117769
-
Modulation of hematopoietic stem cell homing and engraftment by CD26
-
K.W. Christopherson 2nd, G. Hangoc, C.R. Mantel, and H.E. Broxmeyer Modulation of hematopoietic stem cell homing and engraftment by CD26 Science 305 2004 1000 1003
-
(2004)
Science
, vol.305
, pp. 1000-1003
-
-
Christopherson, K.W.1
Hangoc, G.2
Mantel, C.R.3
Broxmeyer, H.E.4
-
22
-
-
0033852128
-
Molecular characterization of dipeptidyl peptidase activity in serum: Soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides
-
C. Durinx, A.M. Lambeir, E. Bosmans, J.B. Falmagne, R. Berghmans, A. Haemers, and et al. Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides Eur. J. biochem./FEBS 267 2000 5608 5613
-
(2000)
Eur. J. Biochem./FEBS
, vol.267
, pp. 5608-5613
-
-
Durinx, C.1
Lambeir, A.M.2
Bosmans, E.3
Falmagne, J.B.4
Berghmans, R.5
Haemers, A.6
-
23
-
-
84909953094
-
Short-term inhibition of DPP-4 enhances endothelial regeneration after acute arterial injury via enhanced recruitment of circulating progenitor cells
-
C. Brenner, N. Krankel, S. Kuehlenthal, L. Israel, F. Remm, C. Fischer, and et al. Short-term inhibition of DPP-4 enhances endothelial regeneration after acute arterial injury via enhanced recruitment of circulating progenitor cells Int. J. Cardiol. 2014 10.1016/j.ijcard.2014.09.016
-
(2014)
Int. J. Cardiol.
-
-
Brenner, C.1
Krankel, N.2
Kuehlenthal, S.3
Israel, L.4
Remm, F.5
Fischer, C.6
-
24
-
-
78650969682
-
The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression
-
L. Sanchez-Martin, A. Estecha, R. Samaniego, S. Sanchez-Ramon, M.A. Vega, and P. Sanchez-Mateos The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression Blood 117 2011 88 97
-
(2011)
Blood
, vol.117
, pp. 88-97
-
-
Sanchez-Martin, L.1
Estecha, A.2
Samaniego, R.3
Sanchez-Ramon, S.4
Vega, M.A.5
Sanchez-Mateos, P.6
-
25
-
-
77958195997
-
The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: Possible role of stromal-derived factor-1alpha
-
G.P. Fadini, E. Boscaro, M. Albiero, L. Menegazzo, V. Frison, S. de Kreutzenberg, and et al. The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha Diabetes Care 33 2010 1607 1609
-
(2010)
Diabetes Care
, vol.33
, pp. 1607-1609
-
-
Fadini, G.P.1
Boscaro, E.2
Albiero, M.3
Menegazzo, L.4
Frison, V.5
De Kreutzenberg, S.6
-
26
-
-
84893162958
-
The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms
-
Y. Zeng, C. Li, M. Guan, Z. Zheng, J. Li, W. Xu, and et al. The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms Cardiovasc. Diabetol. 13 2014 32
-
(2014)
Cardiovasc. Diabetol.
, vol.13
, pp. 32
-
-
Zeng, Y.1
Li, C.2
Guan, M.3
Zheng, Z.4
Li, J.5
Xu, W.6
-
27
-
-
26244463577
-
Atherosclerotic plaque progression and vulnerability to rupture: Angiogenesis as a source of intraplaque hemorrhage
-
R. Virmani, F.D. Kolodgie, A.P. Burke, A.V. Finn, H.K. Gold, T.N. Tulenko, and et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage Arterioscler. Thromb. Vasc. Biol. 25 2005 2054 2061
-
(2005)
Arterioscler. Thromb. Vasc. Biol.
, vol.25
, pp. 2054-2061
-
-
Virmani, R.1
Kolodgie, F.D.2
Burke, A.P.3
Finn, A.V.4
Gold, H.K.5
Tulenko, T.N.6
-
28
-
-
84883765959
-
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
-
B.M. Scirica, D.L. Bhatt, E. Braunwald, P.G. Steg, J. Davidson, B. Hirshberg, and et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus N. Engl. J. Med. 369 2013 1317 1326
-
(2013)
N. Engl. J. Med.
, vol.369
, pp. 1317-1326
-
-
Scirica, B.M.1
Bhatt, D.L.2
Braunwald, E.3
Steg, P.G.4
Davidson, J.5
Hirshberg, B.6
-
29
-
-
84883745765
-
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
-
W.B. White, C.P. Cannon, S.R. Heller, S.E. Nissen, R.M. Bergenstal, G.L. Bakris, and et al. Alogliptin after acute coronary syndrome in patients with type 2 diabetes N. Engl. J. Med. 369 2013 1327 1335
-
(2013)
N. Engl. J. Med.
, vol.369
, pp. 1327-1335
-
-
White, W.B.1
Cannon, C.P.2
Heller, S.R.3
Nissen, S.E.4
Bergenstal, R.M.5
Bakris, G.L.6
-
31
-
-
85044503444
-
Clinical significance of macrophage phenotypes in cardiovascular disease
-
H.J. Medbury, H. Williams, and J.P. Fletcher Clinical significance of macrophage phenotypes in cardiovascular disease Clin. transl. med. 3 2014 63
-
(2014)
Clin. Transl. Med.
, vol.3
, pp. 63
-
-
Medbury, H.J.1
Williams, H.2
Fletcher, J.P.3
-
32
-
-
85040657852
-
Monocyte and macrophage differentiation: Circulation inflammatory monocyte as biomarker for inflammatory diseases
-
J. Yang, L. Zhang, C. Yu, X.F. Yang, and H. Wang Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases Biomark Res. 2 2014 1
-
(2014)
Biomark Res.
, vol.2
, pp. 1
-
-
Yang, J.1
Zhang, L.2
Yu, C.3
Yang, X.F.4
Wang, H.5
-
33
-
-
84879562515
-
Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection
-
(e00264-13)
-
M.J. Davis, T.M. Tsang, Y. Qiu, J.K. Dayrit, J.B. Freij, G.B. Huffnagle, and et al. Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection mBio 4 2013 (e00264-13)
-
(2013)
MBio
, vol.4
-
-
Davis, M.J.1
Tsang, T.M.2
Qiu, Y.3
Dayrit, J.K.4
Freij, J.B.5
Huffnagle, G.B.6
-
34
-
-
30444447501
-
Reverse cholesterol transport and cholesterol efflux in atherosclerosis
-
R. Ohashi, H. Mu, X. Wang, Q. Yao, and C. Chen Reverse cholesterol transport and cholesterol efflux in atherosclerosis QJM 98 2005 845 856
-
(2005)
QJM
, vol.98
, pp. 845-856
-
-
Ohashi, R.1
Mu, H.2
Wang, X.3
Yao, Q.4
Chen, C.5
-
35
-
-
84897403739
-
Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice
-
B. Hewing, S. Parathath, T. Barrett, W.K. Chung, Y.M. Astudillo, T. Hamada, and et al. Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice Arterioscler. Thromb. Vasc. Biol. 34 2014 779 789
-
(2014)
Arterioscler. Thromb. Vasc. Biol.
, vol.34
, pp. 779-789
-
-
Hewing, B.1
Parathath, S.2
Barrett, T.3
Chung, W.K.4
Astudillo, Y.M.5
Hamada, T.6
-
36
-
-
77953952667
-
Concept of vulnerable/unstable plaque
-
A.V. Finn, M. Nakano, J. Narula, F.D. Kolodgie, and R. Virmani Concept of vulnerable/unstable plaque Arterioscler. Thromb. Vasc. Biol. 30 2010 1282 1292
-
(2010)
Arterioscler. Thromb. Vasc. Biol.
, vol.30
, pp. 1282-1292
-
-
Finn, A.V.1
Nakano, M.2
Narula, J.3
Kolodgie, F.D.4
Virmani, R.5
|